Mass balance of pharmaceutical and personal care products in a pilot-scale single-sludge system: Influence of T, SRT and recirculation ratio

Chemosphere

Volumn 89, Issue 2, 2012, Pages 164-171

  Suárez, Sonia ^a   Reif, Rubén ^a   Lema, Juan M ^a   Omil, Francisco ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Biotransformation; PPCPs; Removal; Sorption; Wastewater

Indexed keywords

PILOT PLANTS; REMOVAL; SORPTION; WASTEWATER;

BIODEGRADABLE COMPOUNDS; BIOTRANSFORMATION; INTERNAL RECIRCULATIONS; OPERATION CONDITIONS; PHARMACEUTICAL AND PERSONAL CARE PRODUCTS; PPCPS; REMOVAL EFFICIENCIES; SINGLE-SLUDGE SYSTEM;

ANTIBIOTICS;

ANTIBIOTIC AGENT; CARBAMAZEPINE; CELESTOLIDE; CITALOPRAM; DIAZEPAM; DICLOFENAC; DRUG; ERYTHROMYCIN; ESTRADIOL; ETHINYLESTRADIOL; FLUOXETINE; FRAGRANCE; GALAXOLIDE; IBUPROFEN; NAPROXEN; ROXITHROMYCIN; SULFAMETHOXAZOLE; TONALIDE; TRIMETHOPRIM; UNCLASSIFIED DRUG;

ACCLIMATION; ANTIBIOTICS; BIODEGRADATION; BIOTRANSFORMATION; DENITRIFICATION; MASS BALANCE; POLLUTANT REMOVAL; SLUDGE; SORPTION; VOLATILIZATION;

ACCLIMATIZATION; ACTIVATED SLUDGE; ARTICLE; BIODEGRADABILITY; BIOREACTOR; CONCENTRATION (PARAMETERS); DEGRADATION; DENITRIFICATION; HYGIENE PRODUCT; NITRIFICATION; SLUDGE; SLUDGE RETENTION TIME; TEMPERATURE; TIME; VOLATILIZATION; WASTE COMPONENT REMOVAL;

EID: 84863822513     PISSN: 00456535     EISSN: 18791298     Source Type: Journal    
DOI: 10.1016/j.chemosphere.2012.05.094     Document Type: Article

References (37)

1. American Public Health Association (APHA), 1999. Standard Methods for the Examination of Water and Wastewater, 20th ed., Washington, DC, USA.
2. Baronti C., Curini R., D'Ascenzo G., Di Corcia A., Gentili A., Samperi R. Monitoring natural and synthetic estrogens at activated sludge sewage treatment plants and in a receiving river water. Environ. Sci. Technol. 2000, 34:5059-5066.
3. Bester K. Retention characteristics and balance assessment for two polycyclic musk fragrances (HHCB and AHTN) in a typical German sewage treatment plant. Chemosphere 2004, 57:863-870.
4. Brooks B.W., Riley T.M., Taylor R.D. Water quality of effluent-dominated stream ecosystems: ecotoxicological, hydrological, and management considerations. Hydrobiologia 2006, 556:365-379.
5. Carballa M., Omil F., Lema J.M., Llompart M., Garcia-Jares C., Rodriguez I., Gomez M., Ternes T. Behavior of pharmaceuticals, cosmetics and hormones in a sewage treatment plant. Water Res. 2004, 38:2918-2926.
6. Castiglioni S., Bagnati R., Fanelli R., Pomati F., Calamari D., Zuccato E. Removal of pharmaceuticals in sewage treatment plants in Italy. Environ. Sci. Technol. 2006, 40:357-363.
7. Clara M., Strenn B., Ausserleitner M., Kreuzinger N. Comparison of the behaviour of selected micropollutants in a membrane bioreactor and a conventional wastewater treatment plant. Water Sci. Technol. 2004, 50:29-36.
8. Clara M., Strenn B., Kreuzinger N. Carbamazepine as a possible anthropogenic marker in the aquatic environment: investigations on the behaviour of Carbamazepine in wastewater treatment and during groundwater infiltration. Water Res. 2004, 38:947-954.
9. Clara M., Kreuzinger N., Strenn B., Gans O., Kroiss H. The solids retention time - a suitable design parameter to evaluate the capacity of wastewater treatment plants to remove micropollutants. Water Res. 2005, 39:97-106.
10. Clara M., Strenn B., Gans O., Martinez E., Kreuzinger N., Kroiss H. Removal of selected pharmaceuticals, fragrances and endocrine disrupting compounds in a membrane bioreactor and conventional wastewater treatment plants. Water Res. 2005, 39:4797-4807.
11. Forrez I., Carballa M., Boon N., Verstraete W. Biological removal of 17α-ethinylestradiol (EE2) in an aerated nitrifying fixed bed reactor during ammonium starvation. J. Chem. Technol. Biot. 2008, 84:119-125.
12. Göbel A., Thomsen A., McArdell C.S., Joss A., Giger W. Occurrence and sorption behavior of sulfonamides, macrolides, and trimethoprim in activated sludge. Environ. Sci. Technol. 2005, 39:3981-3989.
13. Göbel A., McArdell C.S., Joss A., Siegrist H., Giger W. Fate of sulfonamides, macrolides, and trimethoprim in different wastewater treatment technologies. Sci. Total Environ. 2007, 372:361-371.
14. Gomez M.J., Martinez Bueno M.J., Lacorte S., Fernandez-Alba A.R., Agüera A. Pilot survey monitoring pharmaceuticals and related compounds in a sewage treatment plant located on the Mediterranean coast. Chemosphere 2007, 66:993-1002.
15. Heberer T., Reddersen K., Mechlinski A. From municipal sewage to drinking water: fate and removal of pharmaceutical residues in the aquatic environment in urban areas. Water Sci. Technol. 2002, 46(3):81-88.
16. Johnson D.J., Sanderson H., Brain R.A., Wilson C.J., Bestari K.T., Solomon K.R. Exposure assessment and microcosm fate of selected selective serotonin reuptake inhibitors. Regul. Toxicol. Pharm. 2005, 42:313-323.
17. Jones O.A.H., Voulvoulis N., Lester J.N. Aquatic environmental assessment of the top 25 English prescription pharmaceuticals. Water Res. 2002, 36:5013-5022.
18. Jones O.A.H., Voulvoulis N., Lester J.N. The occurrence and removal of selected pharmaceutical compounds in a sewage treatment works utilising activated sludge treatment. Environ. Pollut. 2007, 145:738-744.
19. Joss A., Andersen H., Ternes T., Richle P.R., Siegrist H. Removal of estrogens in municipal wastewater treatment under aerobic and anaerobic conditions: consequences for plant optimization. Environ. Sci. Technol. 2004, 38:3047-3055.
20. Joss A., Keller E., Alder A.C., Göbel A., McArdell C.S., Ternes T., Siegrist H. Removal of pharmaceuticals and fragrances in biological wastewater treatment. Water Res. 2005, 39:3139-3152.
21. Joss A., Zabczynski S., Göbel A., Hoffmann B., Loffler D., McArdell C.S., Ternes T.A., Thomsen A., Siegrist H. Biological degradation of pharmaceuticals in municipal wastewater treatment: proposing a classification scheme. Water Res. 2006, 40:1686-1696.
22. Kreuzinger N., Clara M., Strenn B., Kroiss H. Relevance of the sludge retention time (SRT) as design criteria for wastewater treatment plants for the removal of endocrine disruptors and pharmaceuticals from wastewater. Water Sci. Technol. 2004, 50(5):149-156.
23. Kupper T., Plagellat C., Braendli R.C., de Alencastro L.F., Grandjean D., Tarradellas J. Fate and removal of polycyclic musks, UV filters and biocides during wastewater treatment. Water Res. 2006, 40:2603-2612.
24. Lindberg R.H., Wennberg P., Johansson M.I., Tysklind M., Andersson B.A.V. Screening of human antibiotic substances and determination of weekly mass flows in five sewage treatment plants in Sweden. Environ. Sci. Technol. 2005, 39:3421-3429.
25. Nakada N., Tanishima T., Shinohara H., Kiri K., Takada H. Pharmaceutical chemicals and endocrine disrupters in municipal wastewater in Tokyo and their removal during activated sludge treatment. Water Res. 2006, 40:3297-3303.
26. Omil, F., Suárez, S., Carballa, M., Reif, R., Lema, J.M., 2010. Chapter 16: criteria for designing sewage treatment plants for enhanced removal of organic micropollutants. In: Fatta-Kassinos, D., Bester, K., Kümmerer, K. (Eds.), Xenobiotics in the Urban Water Cycle: Mass Flows, Environmental Process, Mitigation and Treatment Strategies, Series: Environmental Pollution, vol. 16. Springer, Dordrecht, pp. 283-306.
27. Perez S., Eichhorn P., Aga D.S. Evaluating the biodegradability of sulfamethazine, sulfamethoxazole, sulfathiazole, and trimethoprim at different stages of sewage treatment. Environ. Toxicol. Chem. 2005, 24:1361-1367.
28. Price P.B., Sowers T. Temperature dependence of metabolic rates for microbial growth, maintenance, and survival. Microbiology 2004, 101:4631-4636.
29. Simonich S.L., Federle T.W., Eckhoff W.S., Rottiers A., Webb S., Sabaliunas D., De Wolf W. Removal of fragrance materials during US and European wastewater treatment. Environ. Sci. Technol. 2002, 36:2839-2847.
30. Stumpf M., Ternes T.A., Wilken R.D., Rodrigues S.V., Baumann W. Polar drug residues in sewage and natural waters in the state of Rio de Janeiro. Sci. Total Environ. 1999, 225:135-141.
31. Suarez S., Lema J.M., Omil F. Removal of pharmaceutical and personal care products (PPCPs) under nitrifying and denitrifying conditions. Water Res. 2010, 44:3214-3224.
32. Ternes T.A. Occurrence of drugs in German sewage treatment plants and rivers. Water Res. 1998, 32:3245-3260.
33. Ternes T.A., Herrmann N., Bonerz M., Knacker T., Siegrist H., Joss A. A rapid method to measure the solid-water distribution coefficient (K-d) for pharmaceuticals and musk fragrances in sewage sludge. Water Res. 2004, 38:4075-4084.
34. Ternes T.A., Joss A., Siegrist H. Scrutinizing pharmaceuticals and personal care products in wastewater treatment. Environ. Sci. Technol. 2004, 38:392A-399A.
35. Vader J.S., van Ginkel C.G., Sperling F.M.G.M., de Jong J., de Boer W., de Graaf J.S., van der Most M., Stokman P.G.W. Degradation of ethinyl estradiol by nitrifying activated sludge. Chemosphere 2000, 41:1239-1243.
36. Vasskog T., Berger U., Samuelsen P.J., Kallenborn R., Jensen E. Selective serotonin reuptake inhibitors in sewage influents and effluents from Tromso, Norway. J. Chromatogr. A 2006, 1115:187-195.
37. Webb S.F. Chapter 25: a data based perspective on the environmental risk assessment of human pharmaceuticals II-Aquatic risk characterisation. Pharmaceuticals in the Environment: Sources, Fate, Effects and Riks 2004, 345-361. Springer, Berlin. K. Kümmerer (Ed.).